Article
Effectiveness of Rimegepant in Vestibular Migraine: A Prospective Self-controlled Cohort Study
2025-11-14
Abstract excerpt
<title>Abstract</title> <p>Background Vestibular migraine (VM) is the second most common cause of episodic vertigo worldwide, yet effective therapeutic options remain limited. This study aimed to assess the clinical effectiveness of rimegepant in patients with VM. Methods A total of 33 VM cases were enrolled in this multicenter, prospective self-controlled cohort study, screened from an initial pool of 106 patien...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 14cadfaf-1388-5102-92bc-814d48387b30
- DOI
- 10.21203/rs.3.rs-8009385/v1
